In last trading session, Clover Health Investments Corp (NASDAQ:CLOV) saw 6.59 million shares changing hands with its beta currently measuring 2.00. Company’s recent per share price level of $4.49 trading at -$0.06 or -1.32% at ring of the bell on the day assigns it a market valuation of $2.25B. That closing price of CLOV’s stock is at a discount of -8.46% from its 52-week high price of $4.87 and is indicating a premium of 86.41% from its 52-week low price of $0.61.
For Clover Health Investments Corp (CLOV), analysts’ consensus is at an average recommendation of Hold while assigning it a mean rating of 2.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 0 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Clover Health Investments Corp (NASDAQ:CLOV) trade information
Upright in the red during last session for losing -1.32%, in the last five days CLOV remained trading in the green while hitting it’s week-highest on Thursday, 02/20/25 when the stock touched $4.49 price level, adding 6.46% to its value on the day. Clover Health Investments Corp’s shares saw a change of 42.54% in year-to-date performance and have moved 0.45% in past 5-day. Clover Health Investments Corp (NASDAQ:CLOV) showed a performance of 5.90% in past 30-days.
Wall Street analysts have assigned a consensus price target of 6 to the stock, which implies a rise of 25.17% to its current value. Analysts have been projecting 6 as a low price target for the stock while placing it at a high target of 6. It follows that stock’s current price would drop -33.63% in reaching the projected high whereas dropping to the targeted low would mean a loss of -33.63% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -585.84% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 73.20% while estimates for its earnings growth in next 5 years are of 46.63%.
Clover Health Investments Corp (NASDAQ:CLOV)’s Major holders
VANGUARD GROUP INC is the top institutional holder at CLOV for having 17.35 million shares of worth $21.33 million. And as of 2024-06-30, it was holding 3.5662 of the company’s outstanding shares.
The second largest institutional holder is RENAISSANCE TECHNOLOGIES LLC, which was holding about 11.27 million shares on 2024-06-30. The number of shares represents firm’s hold over 2.3123 of outstanding shares, having a total worth of $13.86 million.
On the other hand, Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Sep 30, 2024 , the former fund manager was holding 10.94 shares of worth $49.12 million or 2.65% of the total outstanding shares. The later fund manager was in possession of 6.07 shares on Sep 30, 2024 , making its stake of worth around $27.27 million in the company or a holder of 1.47% of company’s stock.
